Delivery Order SPE2DB24D1034-SPE2DB25FWFF4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,296.00 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) pharmaceutical product on August 28, 2025, with an ultimate completion date of August 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing contract vehicle. The product will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $2,135.95 delivery order to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packaging, with an ultimate completion date of August 29, 2025. This is a firm fixed price contract with no set-aside designation, issued competitively to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal contracting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,633.36 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This contract was competitively awarded with no set-aside designation and employs firm fixed pricing. The delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with a contract value of $1,645.21 and a completion date of August 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,183.65 to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Testosterone 1% (25mg/2.5g) in unit dose packaging. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 25, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the open competitive procurement process....
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Testosterone 1% (50 mg/5g) in unit dose 5-gram packets. This delivery order, valued at $1,112.22 with a firm fixed price structure, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award is non-competitive and designated for performance at the contractor's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with a ceiling value of $1,976.82. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The work is scheduled for completion by August 22, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose packets of 5 grams. This competitively awarded, non-set-aside contract carries a ceiling value of $1,493.80 and represents a firm fixed-price delivery order with an ultimate completion date of August 5, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a $1,344.52 delivery order to AmerisourceBergen Drug Corp for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This firm fixed-price delivery order, issued on August 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,652.00 for Testosterone 1% (25mg/2.5g) pharmaceutical product on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through the Defense Logistics Agency's Medical Supply Chain. The place of performance is the company's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- SPE2DB24D1034Indefinite Delivery Contract
- SPE2DB24D1034-SPE2DB25FWFF4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,605.63 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5 gram packages on August 22, 2025, with completion expected by August 25, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million and extending through December 2026. As a pharmaceutical prime vendor, AmerisourceBergen supplies critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies to support military healthcare systems and other federal healthcare customers. The company's federal contracting portfolio demonstrates extensive capability in pharmaceutical distribution across multiple therapeutic domains, establishing it as a key supplier within the DLA Medical Supply Chain serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/22/25 |